Page last updated: 2024-11-07

spironolactone and Porphyria

spironolactone has been researched along with Porphyria in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Derksen, J1
Krulder, JW1

Other Studies

1 other study available for spironolactone and Porphyria

ArticleYear
Spironolactone for porphyria cutanea tarda associated hirsutism.
    Lancet (London, England), 1990, May-05, Volume: 335, Issue:8697

    Topics: Adult; Female; Hirsutism; Humans; Porphyrias; Severity of Illness Index; Spironolactone

1990